AbstractBackground and objectiveStudies have shown that the rate of propofol infusion may influence the predicted propofol concentration at the effect site (Es). The aim of this study was to evaluate the Es predicted by the Marsh pharmacokinetic model (ke0 0.26min−1) in loss of consciousness during fast or slow induction.MethodThe study included 28 patients randomly divided into two equal groups. In slow induction group (S), target-controlled infusion (TCI) of propofol with plasma, Marsh pharmacokinetic model (ke0 0.26min−1) with target concentration (Tc) at 2.0-μgmL−1 were administered. When the predicted propofol concentration at the effect site (Es) reached half of Es value, Es was increased to previous Es+1μgmL−1, successively, until lo...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
BACKGROUND AND OBJECTIVE: Studies have shown that the rate of propofol infusion may influence the pr...
studies have shown that rate of propofol infusion may influence the predicted propofol concentration...
Background and objective: studies have shown that rate of propofol infusion may influence the predic...
Background and objective: Studies have shown that the rate of propofol infusion may influence the pr...
Background and objective: studies have shown that rate of propofol infusion may influence the predic...
AbstractBackground and objectiveStudies have shown that the rate of propofol infusion may influence ...
Background: The authors hypothesized a difference in plasma-effect site equilibration, depicted by a...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
Background: The authors hypothesized a difference in plasma-effect site equilibration, depicted by a...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
BACKGROUND AND OBJECTIVE: Studies have shown that the rate of propofol infusion may influence the pr...
studies have shown that rate of propofol infusion may influence the predicted propofol concentration...
Background and objective: studies have shown that rate of propofol infusion may influence the predic...
Background and objective: Studies have shown that the rate of propofol infusion may influence the pr...
Background and objective: studies have shown that rate of propofol infusion may influence the predic...
AbstractBackground and objectiveStudies have shown that the rate of propofol infusion may influence ...
Background: The authors hypothesized a difference in plasma-effect site equilibration, depicted by a...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
Background: The authors hypothesized a difference in plasma-effect site equilibration, depicted by a...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...
In the ideal pharmacokinetic-dynamic (PK-PD) model for calculating the predicted effect-site concent...